Elevated soluble fms-like tyrosine kinase-1 levels in acute coronary occlusion

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 2, 2011, Pages 443-450

  Kapur, Navin K ^a   Heffernan, Kevin S ^a   Yunis, Adil A ^a   Nguyen, Tuan A ^a   Aronovitz, Mark J ^a   Parpos, Peter ^a   Wilson, Szuhuei ^a   Baker, Corey K ^a   Esposito, Michele L ^a   Shah, Ameer ^a   Kimmelstiel, Carey D ^a   Weintraub, Andrew ^a   Karas, Richard H ^a   Mendelsohn, Michael E ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

acute coronary syndromes; coronary artery disease; coronary heart disease; endothelium; thrombosis

Indexed keywords

CREATINE KINASE MB; THROMBIN; TROPONIN I; VASCULOTROPIN RECEPTOR 1;

ACUTE HEART INFARCTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY; CREATINE KINASE BLOOD LEVEL; ENDOTHELIUM CELL; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MOUSE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; AGED; ANIMALS; CASE-CONTROL STUDIES; CELL HYPOXIA; CELLS, CULTURED; CORONARY OCCLUSION; CREATINE KINASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79551493677     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.215897     Document Type: Article

References (30)

1. Terkelsen CJ, Sørensen JT, Maeng M, Jensen LO, Tilsted HH, Trautner S, Vach W, Johnsen SP, Thuesen L, Lassen JF. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304:763-771.
2. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) [published correction appears in J Am Coll Cardiol. 2001;38:294-295]. J Am Coll Cardiol. 2000;36:970-1062.
3. Hand M, Brown C, Horan M, Simons-Morton D. The National Heart Attack Alert Program: progress at 5 years. J Thromb Thrombolysis. 1998;6:19.
4. Aufderheide TP, Hendley GE, Woo J, Lawrence S, Valley V, Teichman SL. A prospective evaluation of prehospital 12-lead ECG application in chest pain patients. J Electrocardiol. 1992;24:8-13.
5. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173-2195.
6. Friess U, Stark M. Cardiac markers: a clear cause for point-of-care testing. Anal Bioanal Chem. 2009;393:1453-1462.
7. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Münzel TF, Blankenberg S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361:868-877.
8. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci. 1991;88:9267-9271.
9. Kendall RL, Wang G, DiSalvo J, Thomas KA. Specificity of vascular endothelial growth factor receptor ligand binding domains. Biochem Biophys Res Commun. 1994;201:326-330.
10. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 1991;65:1143-1152.
11. Terman BL, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 1991;6:1677-1683.
12. Ma L, Wang X, Zhang Z, Zhou X, Chen A, Yao L. Identification of the ligand-binding domain of human vascular endothelial growth factor receptor Flt-1. Biotechnol Appl Biochem. 2001;34:199-204.
13. Chung NA, Makin AJ, Lip GY. Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay. Eur J Clin Invest. 2003;33:529-535.
14. Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Nishida T, Morikawa Y, Nakagawa H, Tsutsumi T, Sung JH, Takemoto Y, Soeda T, Okayama S, Ishigami K, Kawata H, Horii M, Nakajima T, Saito Y. Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction. Am J Cardiol. 2009;104:1478-1483.
15. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;12:672-683.
16. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006;203:1447-1458.
17. Nagamatsu T, Fujii T, Kusumi M, Li Z, Yamashita T, Osuga Y, Momoeda M, Kozuma S, Taketani Y. Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology. 2004;145:4838-4845.
18. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology. 2004;145:4835-4837.
19. Parenti A, Brogelli L, Filippi S, Donnini S, Ledda F. Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt1/VEGF receptor-1. Cardiovasc Res. 2002;55: 201-212.
20. Rahimi N, Golde TE, Meyer RD. Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells. Cancer Res. 2009;69:2607-2614.
21. Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, Smith JJ, Mendelsohn ME, Konstam MA. Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol. 1998;274:H1812-H1820.
22. Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino-Kenduson M, Lynch MP, Rueda BR, Benita Y, Xavier RJ, Chung DC. HIF-1a and HIF-2a have divergent roles in colon cancer. Int J Cancer. 2009;124:763-771.
23. Brady WJ, Perron AD, Martin ML, Beagle C, Aufderheide TP. Cause of ST segment abnormality in ED chest pain patients. Am J Emerg Med. 2001;19:25-28.
24. Pedersen SH, Galatius S, Hansen PR, Mogelvang R, Abildstrom SZ, Sørensen R, Davidsen U, Galloe A, Abildgaard U, Iversen A, Bech J, Madsen JK, Jensen JS. Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2009;54:2296-2302.
25. Karras DJ, Kane DL. Serum markers in the emergency department diagnosis of acute myocardial infarction. Emerg Med Clin North Am. 2001;19:321-337.
26. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997;337:1648-1653.
27. Pope JH, Selker HP. Diagnosis of acute cardiac ischemia. Emerg Med Clin North Am. 2003;21:27-59.
28. Balk EM, Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med. 2001;37:478-494. (Pubitemid 32417573)
29. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AH, Christenson RH. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115:e356-e375.
30. Carr DB, Tran LT, Brateng DA, Kawamura C, Shofer JB, Karumanchi SA, Easterling TR. Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy. Hypertens Pregnancy. 2009;28:42-55.